
Bhagiradha Chemicals & Industries ranks 8th by market capitalisation among 14 Pesticides & Agrochemicals companies tracked by ATS. Its largest peers are UPL, PI Industries and Sumitomo Chemical India. Its P/E of 111.4 compares with a peer median of 21.5.
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| UPL | 499.20 | -2.03% | 42,141 | 21.6 | 1.21 | 5.5% | +12.5% |
| PI Industries | 2,204.70 | -2.01% | 33,447 | 28.7 | 2.98 | 12.4% | +12.5% |
| Sumitomo Chemical India | 422.45 | +1.05% | 21,086 | 36.4 | 6.22 | 17.3% | +12.5% |
| Bayer Cropscience | 3,489.00 | -1.26% | 15,680 | 21.4 | 5.29 | 23.7% | +12.5% |
| Sharda Cropchem | 743.00 | +0.17% | 6,703 | 10.7 | 2.14 | 24.2% | +12.5% |
| Dhanuka Agritech | 891.35 | -2.00% | 4,018 | 15.0 | 2.39 | 18.6% | +12.5% |
| Rallis India | 200.00 | -0.15% | 3,889 | 18.2 | 1.90 | 9.3% | +12.5% |
| Bhagiradha Chemicals & Industries | 236.35 | -1.48% | 3,065 | 111.4 | 4.39 | 2.6% | — |
| GSP Crop Science | 482.80 | +1.29% | 2,246 | 22.3 | 3.20 | 16.4% | +12.5% |
| Astec LifeSciences | 742.35 | +5.34% | 1,654 | 22.5 | 4.23 | -25.9% | +12.5% |
| Bharat Rasayan | 989.00 | -0.93% | 1,644 | 11.5 | 1.29 | 12.1% | +12.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Bhagiradha Chemicals & Industries' listed peers in Pesticides & Agrochemicals include UPL, PI Industries, Sumitomo Chemical India, Bayer Cropscience, Sharda Cropchem and Dhanuka Agritech, ranked here by market capitalisation.
Bhagiradha Chemicals & Industries trades at a P/E of 111.4, against a median of 21.5 across the 10 Pesticides & Agrochemicals peers shown.
By market capitalisation, the largest company in the group is UPL at ₹42,141 crore, against ₹3,065 crore for Bhagiradha Chemicals & Industries.
Track BHAGCHEM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.